At a 2026 obesity conference in Beijing, Chinese experts declared a paradigm shift in treating obesity, prioritizing long-term metabolic health over short-term weight loss, while global data from the WHO highlights the escalating scale of the crisis.
At the 2026 China Obesity Congress, Ji Linong, executive president of the China Obesity Congress and a professor at Peking University People’s Hospital, outlined a transformative approach to obesity care. The event, held August 8–10, marked a turning point where medical professionals began measuring success not just by weight reduction but by metabolic improvements, cardiovascular protection, and adherence to treatment regimens. Ji emphasized that the shift, which began in 2021 with the advent of GLP-1 receptor agonists like semaglutide, demonstrated average weight losses of 15 percent alongside cardiovascular benefits, challenging the perception of obesity as a matter of willpower.
The Shift in Obesity Care Framework
Ji described the evolution of obesity treatment through the lens of the Chronic Care Model, a framework designed to address chronic diseases systematically. This model, introduced during his speech, aims to restructure how physicians approach obesity by integrating specialized clinics, revised medical guidelines, and sustained patient engagement. However, Ji identified six persistent barriers to effective care, including patient misconceptions about medical weight loss, the difficulty of maintaining lifestyle changes, and social stigma that discourages professional help. The health care professionals basically need to learn the communication skills needed for obesity care from scratch due to the strong social and psychological nature of obesity,
he said.
To address these challenges, Ji’s China Obesity Education Initiative has developed toolkits for frontline health workers, including patient self-management brochures, communication scripts, and anti-discrimination messaging. These resources are intended to foster trust through motivational interviewing techniques. Despite these efforts, Ji acknowledged that obesity medicine remains an immature field,
urging greater international collaboration to accelerate research and avoid redundant trials.
Global Context and Regional Disparities
The WHO’s 2022 data underscores the urgency of this shift. The organization reported that 1 in 8 people globally were living with obesity, with adult obesity more than doubling since 1990 and adolescent obesity quadrupling. In 2022, 2.5 billion adults were overweight, including 890 million with obesity, while 35 million children under 5 were overweight. The WHO classified obesity as a chronic, relapsing disease driven by genetic, environmental, and behavioral factors, noting that obesogenic environments
have fueled the crisis worldwide.
Regional disparities highlight the complexity of the issue. While the Americas saw the highest prevalence of overweight adults at 67 percent, the WHO South-East Asia and African Regions reported 31 percent. Among children, nearly half of overweight or obese cases in 2024 were in Asia, reflecting the rapid rise of obesity in low- and middle-income countries. The WHO also emphasized that obesity is no longer confined to high-income nations, with 12.1 percent more overweight children under 5 in Africa since 2000.
Challenges in Treatment and Patient Behavior
Despite advances in pharmacological treatments, significant hurdles remain. Ji highlighted that many patients equate medical weight loss with cosmetic slimming, leading to unrealistic expectations and premature discontinuation of medications. He cited the dual burden of social stigma and aesthetic pressures, warning that weight loss driven by shame is the least sustainable
and carries the highest relapse risk.
Next Steps and Systemic Reforms
Experts agree that systemic reforms are critical to addressing obesity as a chronic condition. This change reflects growing awareness but also highlights the need for standardized care protocols.
The WHO’s report emphasizes the importance of early intervention, particularly for children, whose obesity rates have surged since 1990. With 160 million children and adolescents aged 5–19 living with obesity in 2022, the organization advocates for policies that promote healthy diets, physical activity, and access to care. Meanwhile, the China Obesity Congress’s focus on long-term health outcomes signals a broader movement toward treating obesity as a chronic disease rather than a temporary condition.
As the medical community refines its approach, the next critical step will be implementing the Chronic Care Model on a larger scale. This includes expanding access to specialized clinics, training healthcare providers in motivational communication, and addressing systemic barriers like drug accessibility and insurance coverage. The success of these efforts will determine whether the shift from short-term weight loss to long-term health becomes a global standard.
Worth a look
